Literature DB >> 33525543

Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines.

George W Carnell1, Claudia M Trombetta2, Francesca Ferrara1, Emanuele Montomoli2,3, Nigel J Temperton1.   

Abstract

Influenza B is responsible for a significant proportion of the global morbidity, mortality and economic loss caused by influenza-related disease. Two antigenically distinct lineages co-circulate worldwide, often resulting in mismatches in vaccine coverage when vaccine predictions fail. There are currently operational issues with gold standard serological assays for influenza B, such as lack of sensitivity and requirement for specific antigen treatment. This study encompasses the gold standard assays with the more recent Pseudotype-based Microneutralisation assay in order to study comparative serological outcomes. Haemagglutination Inhibition, Single Radial Haemolysis and Pseudotype-based Microneutralisation correlated strongly for strains in the Yamagata lineage; however, it correlated with neither gold standard assays for the Victoria lineage.

Entities:  

Keywords:  influenza B viruses; serology

Year:  2021        PMID: 33525543      PMCID: PMC7911544          DOI: 10.3390/vaccines9020100

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  56 in total

1.  Conformationally selective biophysical assay for influenza vaccine potency determination.

Authors:  Yingxia Wen; Liqun Han; Giuseppe Palladino; Annette Ferrari; Yuhong Xie; Andrea Carfi; Philip R Dormitzer; Ethan C Settembre
Journal:  Vaccine       Date:  2015-09-06       Impact factor: 3.641

2.  Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses.

Authors:  Claudia Maria Trombetta; Daniele Perini; Licia Vitale; Rebecca Jane Cox; Valerio Stanzani; Simona Piccirella; Emanuele Montomoli
Journal:  J Immunol Methods       Date:  2015-04-22       Impact factor: 2.303

3.  Serological diagnosis of influenza B virus infection: comparison of an enzyme-linked immunosorbent assay and the hemagglutination inhibition test.

Authors:  R Turner; J L Lathey; L P Van Voris; R B Belshe
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

4.  Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79.

Authors:  A P Kendal; T R Cate
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

5.  MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.

Authors:  Eva Böttcher; Catharina Freuer; Torsten Steinmetzer; Hans-Dieter Klenk; Wolfgang Garten
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

6.  Multiple genotypes of influenza B virus circulated between 1979 and 2003.

Authors:  Jonathan A McCullers; Takehiko Saito; Amy R Iverson
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  The rationale for quadrivalent influenza vaccines.

Authors:  Christopher S Ambrose; Myron J Levin
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

8.  Titer on chip: new analytical tool for influenza vaccine potency determination.

Authors:  Laura R Kuck; Michelle Sorensen; Erin Matthews; Indresh Srivastava; Manon M J Cox; Kathy L Rowlen
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

9.  A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.

Authors:  Falko Schmeisser; Anupama Vasudevan; Jackeline Soto; Arunima Kumar; Ollie Williams; Jerry P Weir
Journal:  Influenza Other Respir Viruses       Date:  2014-08-02       Impact factor: 4.380

10.  Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses.

Authors:  Claudia Maria Trombetta; Edmond J Remarque; Daniella Mortier; Emanuele Montomoli
Journal:  Influenza Other Respir Viruses       Date:  2018-08-11       Impact factor: 4.380

View more
  1 in total

1.  Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.

Authors:  Francesca Ferrara; Joanne Marie M Del Rosario; Kelly A S da Costa; Rebecca Kinsley; Simon Scott; Sasan Fereidouni; Craig Thompson; Paul Kellam; Sarah Gilbert; George Carnell; Nigel Temperton
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.